Literature DB >> 22367970

Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.

Maria Manczak1, P Hemachandra Reddy.   

Abstract

We recently reported increased mitochondrial fission and decreased fusion, increased amyloid beta (Aβ) interaction with the mitochondrial fission protein Drp1, increased mitochondrial fragmentation, impaired axonal transport of mitochondria and synaptic degeneration in neurons affected by AD. In the present study, we extended our previous investigations to determine whether phosphorylated tau interacts with Drp1 and to elucidate mitochondrial damage in the progression of AD. We also investigated GTPase activity, which is critical for mitochondrial fragmentation, in postmortem brain tissues from patients with AD and brain tissues from APP, APP/PS1 and 3XTg.AD mice. Using co-immunoprecipitation and immunofluorescence analyses, for the first time, we demonstrated the physical interaction between phosphorylated tau and Drp1. Mitochondrial fission-linked GTPase activity was significantly elevated in the postmortem frontal cortex tissues from AD patients and cortical tissues from APP, APP/PS1 and 3XTg.AD mice. On the basis of these findings, we conclude that Drp1 interacts with Aβ and phosphorylated tau, likely leading to excessive mitochondrial fragmentation, and mitochondrial and synaptic deficiencies, ultimately possibly leading to neuronal damage and cognitive decline. Treatment designed to reduce the expression of Drp1, Aβ and/or phosphorylated tau may decrease the interaction between Drp1 and phosphorylated tau and the interaction between Drp1 and Aβ, conferring protection to neurons from toxic insults of excessive Drp1, Aβ and/or phosphorylated tau.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367970      PMCID: PMC3349426          DOI: 10.1093/hmg/dds072

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  50 in total

Review 1.  Neurodegenerative tauopathies.

Authors:  V M Lee; M Goedert; J Q Trojanowski
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 2.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

3.  Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

Authors:  Salvatore Oddo; Antonella Caccamo; Jason D Shepherd; M Paul Murphy; Todd E Golde; Rakez Kayed; Raju Metherate; Mark P Mattson; Yama Akbari; Frank M LaFerla
Journal:  Neuron       Date:  2003-07-31       Impact factor: 17.173

4.  Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.

Authors:  Jia Yao; Ronald W Irwin; Liqin Zhao; Jon Nilsen; Ryan T Hamilton; Roberta Diaz Brinton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

5.  Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Shannon McWeeney; Byung S Park; Maria Manczak; Ramana V Gutala; Dara Partovi; Youngsin Jung; Vincent Yau; Robert Searles; Motomi Mori; Joseph Quinn
Journal:  Hum Mol Genet       Date:  2004-04-28       Impact factor: 6.150

Review 6.  Going new places using an old MAP: tau, microtubules and human neurodegenerative disease.

Authors:  M L Garcia; D W Cleveland
Journal:  Curr Opin Cell Biol       Date:  2001-02       Impact factor: 8.382

7.  Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice.

Authors:  Naotada Ishihara; Masatoshi Nomura; Akihiro Jofuku; Hiroki Kato; Satoshi O Suzuki; Keiji Masuda; Hidenori Otera; Yae Nakanishi; Ikuya Nonaka; Yu-Ichi Goto; Naoko Taguchi; Hidetaka Morinaga; Maki Maeda; Ryoichi Takayanagi; Sadaki Yokota; Katsuyoshi Mihara
Journal:  Nat Cell Biol       Date:  2009-07-05       Impact factor: 28.824

8.  Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.

Authors:  E-M Mandelkow; K Stamer; R Vogel; E Thies; E Mandelkow
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

Review 9.  Pathways towards and away from Alzheimer's disease.

Authors:  Mark P Mattson
Journal:  Nature       Date:  2004-08-05       Impact factor: 49.962

10.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress.

Authors:  K Stamer; R Vogel; E Thies; E Mandelkow; E-M Mandelkow
Journal:  J Cell Biol       Date:  2002-03-18       Impact factor: 10.539

View more
  173 in total

Review 1.  Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress.

Authors:  Mohammed Akbar; Musthafa Mohamed Essa; Ghazi Daradkeh; Mohamed A Abdelmegeed; Youngshim Choi; Lubna Mahmood; Byoung-Joon Song
Journal:  Brain Res       Date:  2016-02-13       Impact factor: 3.252

Review 2.  Dynamin-related protein-1 as potential therapeutic target in various diseases.

Authors:  Surinder Singh; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

Review 3.  Mitochondrial protein quality control in health and disease.

Authors:  Michael J Baker; Catherine S Palmer; Diana Stojanovski
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

4.  Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease.

Authors:  P Hemachandra Reddy; Maria Manczak; XiangLing Yin; Arubala P Reddy
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 5.  In vivo functions of Drp1: lessons learned from yeast genetics and mouse knockouts.

Authors:  Hiromi Sesaki; Yoshihiro Adachi; Yusuke Kageyama; Kie Itoh; Miho Iijima
Journal:  Biochim Biophys Acta       Date:  2013-12-08

Review 6.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

Review 8.  Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases.

Authors:  Carlotta Giorgi; Saverio Marchi; Ines C M Simoes; Ziyu Ren; Giampaolo Morciano; Mariasole Perrone; Paulina Patalas-Krawczyk; Sabine Borchard; Paulina Jędrak; Karolina Pierzynowska; Jędrzej Szymański; David Q Wang; Piero Portincasa; Grzegorz Węgrzyn; Hans Zischka; Pawel Dobrzyn; Massimo Bonora; Jerzy Duszynski; Alessandro Rimessi; Agnieszka Karkucinska-Wieckowska; Agnieszka Dobrzyn; Gyorgy Szabadkai; Barbara Zavan; Paulo J Oliveira; Vilma A Sardao; Paolo Pinton; Mariusz R Wieckowski
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-22       Impact factor: 6.813

Review 9.  Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer's disease.

Authors:  Jangampalli Adi Pradeepkiran; Arubala P Reddy; P Hemachandra Reddy
Journal:  Drug Discov Today       Date:  2018-11-16       Impact factor: 7.851

Review 10.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.